Medera, Novoheart announce collaboration with scientists at University of CA

Medera and Novoheart announced a groundbreaking collaboration with physician-scientists at the University of California San Diego School of Medicine and Mayo Clinic. The goal of the partnership is to develop the first human mini-heart models of hypoplastic left heart syndrome using stem cells from real patients and improve the understanding of this disease with the goal of developing more personalized treatment strategies for children born with this devastating condition. On September 5, 2024, Medera and Keen Vision Acquisition (KVAC) Corporation, announced they had entered into a definitive merger agreement